{"id":"W4387462087","doi":"10.1016/j.cardfail.2023.09.002","title":"Safety Indicators in Patients Receiving High-intensity Care After Hospital Admission for Acute Heart Failure: The STRONG-HF Trial","year":2023,"lang":"en","type":"article","venue":"Journal of Cardiac Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"ca_institutions":"Surgical Specialties (Canada)","funders":"Medical Research Council; Servier; Novo Nordisk; National Medical Research Council; Cytokinetics; Strong; Vifor Pharma; Pfizer; LivaNova; Amgen; Edwards Lifesciences; Alnylam Pharmaceuticals; Sanofi; American Heart Association; Abbott Vascular; Abbott Laboratories; AstraZeneca","keywords":"Medicine; Heart failure; Hazard ratio; Tolerability; Confidence interval; Natriuretic peptide; Internal medicine; Renal function; Guideline; Cardiology; Adverse effect; Heart rate; Blood pressure","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006762809,0.0002602896,0.0008372147,0.0005284832,0.0001302388,0.00004968502,0.0001362995,0.0001750201,0.00003629415],"category_scores_gemma":[0.0002824914,0.0001623237,0.0007017647,0.0006463043,0.00004627375,0.000217445,0.0001032717,0.0004653813,0.00002369618],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003263953,"about_ca_system_score_gemma":0.0001901881,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008675124,"about_ca_topic_score_gemma":0.00001596064,"domain_scores_codex":[0.9978067,0.0001251861,0.0006566404,0.000254802,0.0007171838,0.0004395328],"domain_scores_gemma":[0.9986438,0.0001563643,0.0002738921,0.0003275532,0.0003448836,0.0002534756],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.0375148,0.0004145542,0.4068094,0.0001405903,0.001926963,0.0001307924,0.002815225,0.00002194722,0.00008642492,0.00004146101,0.5389593,0.01113865],"study_design_scores_gemma":[0.03062753,0.003378522,0.5167307,0.0003352699,0.001072365,0.000006278784,0.002189001,0.000003653555,0.0002661235,0.00001604314,0.4451545,0.0002200938],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9570576,0.0001397439,0.00002041431,0.03849804,0.002193804,0.001966381,0.00004995376,0.00003813539,0.00003595182],"genre_scores_gemma":[0.9967725,0.00005972526,0.001605678,0.0001878613,0.0009730324,0.0000697494,0.00008680946,0.00003985304,0.0002047611],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1099213,"threshold_uncertainty_score":0.6619369,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006357610077282144,"score_gpt":0.2608015017056808,"score_spread":0.2544438916283986,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}